VitVio opens Vetro AI platform to hospitals worldwide

VitVio is expanding access to Vetro, its 3D-native AI platform for operating room intelligence, after early deployments in the US, Europe and the UK. The launch targets hospitals and health systems that want more OR visibility, fewer delays and better use of surgical capacity.

Why it matters: - Vetro is designed to turn operating room activity into a live, structured record, which can help hospitals reduce wasted theatre time and improve surgical throughput. - VitVio says hospitals using Vetro can see profitability rise 23%, depending on hospital and procedure type. - The company says adding just one extra hour-long case a day can increase a single operating suite’s profitability by $300,000 a year. - The system is built to anonymize data at capture and is fully compliant, which matters for privacy-sensitive clinical settings.

What happened: - VitVio opened access to Vetro, its 3D-native AI platform for operating room intelligence, to hospitals and health systems. - The launch follows deployments in select operating theatres across the US, Europe and the UK. - Vetro is now live in operating rooms across the US and the UK. - The platform is now available to hospitals and health systems across the US, Europe, Latin America, the UK and the Middle East, with more regions to follow.

The details: - Vetro uses a multi-camera system, ambient sensing and computer vision to continuously feed 3D data into VitVio’s Spatial Context Engine. - The platform builds live spatial maps and converts movement by people, instruments and equipment into a structured record of what is happening, when, where and why. - Vetro can detect case start and end times, flag delays, orchestrate staff, cut tool waste and automate reports. - VitVio says the platform is focused on processes rather than people, and all data is anonymized at the point of capture. - The company describes Vetro as the world’s first and only 3D clinical sensing system. - VitVio was founded in 2024 by Thomas Knox, Dr Peter Rennert, Maks Kozarzewski and Aleks Pajewski. - VitVio previously announced a partnership with the Royal Orthopaedic Hospital NHS Foundation Trust. - New partners include leading New York hospitals, private hospital groups in Los Angeles and London, and NHS teaching hospitals. - Further partner announcements are expected in the coming months. - VitVio has raised $10 million in total funding, including an $8 million seed round closed in October 2025 led by Bek Ventures. - VitVio operates across the US and Europe. - More information is available on VitVio’s website.

Between the lines: - The launch suggests VitVio is shifting from early clinical validation to broader commercial rollout. - The emphasis on 3D sensing and ambient capture positions Vetro as a more automated alternative to 2D systems that still rely on manual entry. - The privacy framing signals that the company is aiming to reduce one of the biggest barriers to AI adoption in operating rooms.

What's next: - VitVio expects additional partnership announcements in the coming months. - The company plans to keep expanding into new regions as adoption grows. - Thomas Knox said the company spent two years building Vetro to work under real pressure in real operating rooms and now wants to bring that impact to hospitals and health systems worldwide.